Zoetis  logo
Zoetis ZTS
$ 85.52 2.65%
report update icon

Quarterly report 2026-Q3
added 11-05-2026

Zoetis Market Cap | ZTS

As of November 19, 2026 Zoetis has a market cap of $ 37.9 B


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Zoetis

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
56.1 B 75.2 B 84.4 B 80.7 B 94.6 B 72.8 B 66 B 41.1 B 38.4 B 26.9 B 21.5 B 21.4 B 15.3 B - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
94.6 B 15.3 B 53.4 B

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc.
FPRX
616 M - - $ 1.77 B usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
139 M $ 1.33 -1.48 % $ 169 M schweizSchweiz
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
1.61 B $ 33.1 0.29 % $ 1.9 B usaUSA
Ardelyx Ardelyx
ARDX
1.62 B $ 3.15 -1.1 % $ 759 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
334 M $ 0.41 2.22 % $ 105 M usaUSA
Alector Alector
ALEC
247 M $ 2.56 1.17 % $ 264 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
114 M $ 0.97 -3.11 % $ 52 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
4.31 B $ 21.81 3.27 % $ 6.83 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
847 M $ 4.12 1.6 % $ 789 M canadaCanada
Agenus Agenus
AGEN
97.8 M $ 6.39 2.82 % $ 190 M usaUSA
PolyPid Ltd. PolyPid Ltd.
PYPD
67.7 M $ 6.52 -0.31 % $ 107 M israelIsrael
AbCellera Biologics AbCellera Biologics
ABCL
962 M $ 11.0 -0.32 % $ 3.29 B canadaCanada
Artelo Biosciences Artelo Biosciences
ARTL
255 K $ 1.5 -10.71 % $ 284 K usaUSA
Immatics N.V. Immatics N.V.
IMTX
735 M $ 6.11 -2.94 % $ 748 M germanyGermany
Aptevo Therapeutics Aptevo Therapeutics
APVO
1.42 M $ 0.45 -3.45 % $ 142 K usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
65.9 M $ 1.3 -4.41 % $ 12.9 M usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
385 M $ 3.48 2.81 % $ 427 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
2.48 B $ 28.47 -0.07 % $ 4.32 B usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
7.49 M $ 0.89 -3.51 % $ 2.32 M usaUSA
Larimar Therapeutics Larimar Therapeutics
LRMR
371 M $ 3.22 7.69 % $ 268 M usaUSA
Biofrontera AG Biofrontera AG
BFRA
220 M - -8.24 % $ 105 M germanyGermany
Pulmatrix Pulmatrix
PULM
5.08 B $ 1.34 -2.19 % $ 4.89 B usaUSA
Intellia Therapeutics Intellia Therapeutics
NTLA
776 M $ 9.68 -1.07 % $ 1.05 B usaUSA
Pharming Group N.V. Pharming Group N.V.
PHAR
11.8 B $ 12.48 3.51 % $ 8.6 B niderlandNiderland
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
80.6 M - -6.97 % $ 657 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
1.45 B $ 8.04 -4.4 % $ 374 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.25 B $ 29.66 1.91 % $ 1.39 B usaUSA
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
12.3 B $ 14.98 1.28 % $ 12.5 B indiaIndia
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
4.56 B - 1.68 % $ 4.65 B chinaChina
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
81.3 B $ 945.14 -1.32 % $ 98.9 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
467 M $ 3.78 2.16 % $ 404 M usaUSA
Jaguar Health Jaguar Health
JAGX
956 K $ 0.35 -8.69 % $ 816 K usaUSA
Arvinas Arvinas
ARVN
869 M $ 6.77 -0.73 % $ 480 M usaUSA
Cerus Corporation Cerus Corporation
CERS
496 M $ 1.95 2.63 % $ 372 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
3.2 B $ 21.03 1.82 % $ 2.08 B usaUSA
Inhibrx Inhibrx
INBX
1.75 B $ 68.87 -7.16 % $ 3.25 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
18.9 B $ 68.76 0.12 % $ 29.6 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
89.6 M $ 3.24 8.0 % $ 150 M israelIsrael
Revolution Medicines Revolution Medicines
RVMD
19.6 B $ 159.7 -1.84 % $ 30.4 B usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
521 M - - $ 459 M usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
6.91 B $ 16.25 0.87 % $ 5.99 B usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
931 M $ 1.91 -1.55 % $ 263 M usaUSA
Krystal Biotech Krystal Biotech
KRYS
8.46 B $ 314.77 5.43 % $ 9.11 B usaUSA
Kura Oncology Kura Oncology
KURA
735 M $ 7.34 -2.07 % $ 644 M usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
160 M $ 1.39 0.36 % $ 137 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
986 M $ 5.31 -3.45 % $ 387 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
198 M $ 0.27 -3.26 % $ 45 M usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
98.5 M $ 1.69 3.37 % $ 79.2 M usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
318 M $ 10.19 0.22 % $ 805 M usaUSA
SIGA Technologies SIGA Technologies
SIGA
404 M $ 2.81 2.75 % $ 201 M usaUSA